In contrast to the MCF10A mammary epithelial cells, ERα+ MCF7 breast cancer cells demonstrate an increase in activating histone marks H3K4ac, H3K4me3 and H3K27ac upon treatment with either steroid compound (E2 or EC10). This evidence concerns the gene ESR1 and breast cancer.